Company news

Waters Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software

October 28, 2026

Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

October 23, 2026

Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option

October 20, 2026

IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease

October 19, 2026

Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release

October 13, 2026

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

October 1, 2026

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

September 14, 2026

Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference

September 11, 2026

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

August 4, 2026

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

July 27, 2026

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

July 2, 2026

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

June 24, 2026

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

June 9, 2026

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

June 8, 2026

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

June 3, 2026

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

June 1, 2026

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

June 1, 2026

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

May 5, 2026

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

April 20, 2026

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

April 14, 2026

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

April 8, 2026

Waters Prices Offering of Senior Notes

March 18, 2026

NanoImaging Services Appoints Fraser McLeod as Chief Executive Officer to Lead Next Phase of Growth

March 10, 2026

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

March 9, 2026

Waters Corporation to Present at the TD Cowen Health Care Conference

February 23, 2026

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

February 17, 2026

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

February 9, 2026

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

February 9, 2026

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

January 27, 2026

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

January 20, 2026

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

December 23, 2025

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

November 11, 2025

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

November 11, 2025

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

November 4, 2025

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

October 13, 2025

Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call

October 1, 2025

Waters Corporation to Present at the Wells Fargo Healthcare Conference

August 26, 2025

Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

August 4, 2025

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

July 14, 2025

Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

July 11, 2025

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

June 17, 2025

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

June 3, 2025

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality

May 28, 2025

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

May 21, 2025

Waters Corporation to Present at the Jefferies Global Healthcare Conference

May 16, 2025

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

May 12, 2025

Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results

May 6, 2025

Waters Corporation Schedules First Quarter 2025 Earnings Conference Call

April 8, 2025

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC

April 1, 2025

Waters Corporation to Present at the Leerink Partners Global Healthcare Conference

March 7, 2025

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 36 decks. Every deck is listed under its year.